Rectal Cancer: Are 12 Lymph Nodes the Limit?
Open Access
Abstract
Lymph node dissection is a crucial element of oncologic rectal surgery. Many guidelines regard the removal of at least 12 lymph nodes as the quality criterion in rectal cancer. However, this recommendation remains controversial. This study examines the factors influencing the lymph node yield and the validity of the 12-lymph node limit. Patients with rectal cancer who underwent low anterior resection or abdominoperineal amputation between 2000 and 2010 were analyzed. In total, 20,966 patients from 381 hospitals were included. Less than 12 lymph nodes were found in 20.53% of men and 19.31% of women (p = 0.03). The number of lymph nodes yielded increased significantly from 2000, 2005 and 2010 within the quality assurance program for all procedures. The univariate analysis indicated a significant (p < 0.001) correlation between lymph node yield and gender, age, pre-therapeutic T-stage, risk factors and neoadjuvant therapy. The multivariate analyses found T3 stage, female sex, the presence of at least one risk factor and neoadjuvant therapy to have a significant influence on yield. The probability of finding a positive lymph node was proportional to the number of examined nodes with no plateau. There is a proportional relationship between the number of examined lymph nodes and the probability of finding an infiltrated node. Optimal surgical technique and pathological evaluation of the specimen cannot be replaced by a numeric cut-off value.Keywords
This publication has 75 references indexed in Scilit:
- Adequate lymph node recovery improves survival in colorectal cancer patientsJournal of Surgical Oncology, 2013
- Contributing Factors on Lymph Node Yield after Surgery for Mid-Low Rectal CancerYonsei Medical Journal, 2013
- The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancerWorld Journal of Surgical Oncology, 2013
- Challenging the Feasibility and Clinical Significance of Current Guidelines on Lymph Node Examination in Rectal Cancer in the Era of Neoadjuvant TherapyJournal of Clinical Oncology, 2011
- Lymphangiogenesis in Regional Lymph Nodes Is an Independent Prognostic Marker in Rectal Cancer Patients after Neoadjuvant TreatmentPLOS ONE, 2011
- Quality assessment of colorectal cancer care: an international online modelColorectal Disease, 2010
- Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancerCancer, 2010
- Systemic Treatment of Colorectal CancerGastroenterology, 2008
- Comparison of risk factors for colon and rectal cancerInternational Journal of Cancer, 2003
- Extrafascial excision of the rectum for rectal cancerBritish Journal of Surgery, 1998